Dr. Lang is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
6350 Stevens Forest Rd
Ste 101
Columbia, MD 21046Phone+1 410-992-7440Fax+1 443-276-0349
Education & Training
- University of MarylandFellowship, Rheumatology, 1997 - 1999
- Duke University HospitalFellowship, Rheumatology, 1996 - 1997
- Duke University HospitalResidency, Internal Medicine, 1993 - 1996
- University of Maryland School of MedicineClass of 1993
Certifications & Licensure
- MD State Medical License 1997 - 2026
- NC State Medical License 1996 - 1998
- American Board of Internal Medicine Rheumatology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification NextGen Ambulatory EHR, NextGen Healthcare, 2013
Clinical Trials
- Impact of Guided Care With the Vectra Multi-biomarker Disease Activity (MBDA) Blood Test Start of enrollment: 2018 Oct 22
- A Study of Baricitinib in Participants With Rheumatoid Arthritis Start of enrollment: 2020 Feb 14
Publications & Presentations
PubMed
- 165 citationsEstrogen as an immunomodulator.Thomas J. Lang
Clinical Immunology. 2004-12-01 - 127 citationsIn Vivo Neutralization of TNF-α Promotes Humoral Autoimmunity by Preventing the Induction of CTLCharles S. Via, Andrei Shustov, Violeta Rus, Thomas J. Lang, Phuong Nguyen
Journal of Immunology. 2001-12-15 - 63 citationsIn Vivo CD86 Blockade Inhibits CD4+ T Cell Activation, Whereas CD80 Blockade Potentiates CD8+ T Cell Activation and CTL Effector FunctionThomas J. Lang, Phuong Nguyen, Robert J. Peach, William C. Gause, Charles S. Via
Journal of Immunology. 2002-04-15
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: